![Lisa M Campbell Regulatory Analyst Bergeson Campbell law firm](/sites/default/files/styles/author_profile/public/2023-12/12_29_23%20Carla%20Hutton.jpg?h=506c123e&itok=Utzt7Gy1)
Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.
Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.
Carla Hutton's strengths include the ability to provide quickly and efficiently timely, relevant, and accurate information on specific issues for clients. Through daily monitoring of regulatory news, EPA information and other resources, she stays on top of government agency and legislative developments as they occur and quickly prepares notifications on various issues. Ms. Hutton has authored several assessments for client-specific materials. Prepared under tight deadlines, these documents still provide detailed analysis of state, federal, and international regulatory trends and developments.
Representative Engagements:
- Writes a metal-specific quarterly regulatory update for an international association of producers, users, and traders.
- Prepares and writes a quarterly update focused on chemical management regulations in Asia for metals industry associations.
- Authors items for the Nano and Other Emerging Chemical Technologies Blog, which reports on federal, local, and international regulatory, legal, and policy developments and is utilized by clients in nanotechnologies and other chemical technologies.
- Prepares a chemical-specific global assessment of regulatory developments and trends, analyzing the triggers initiating the regulatory initiatives, including scientific developments and regulatory actions undertaken in response by environmental activists, public health activists, and related stakeholders, as well as other complicating factors.
More Legal and Business Bylines From Carla N. Hutton
- OSHA’s Proposed Updates to Hazard Communication Standard Will Include Particle Characteristics - (Posted On Thursday, February 11, 2021)
- EPA Updates TSCA CBI Review Statistics - (Posted On Thursday, February 11, 2021)
- EC DG Invites Offers for Study on Providing Market Data about Nanotechnology to Enhance Transparency - (Posted On Wednesday, February 10, 2021)
- Biden-Harris EPA Provides Updates on Chemical Safety Actions - (Posted On Monday, February 08, 2021)
- EPA Announces Latest Update to the TSCA Inventory - (Posted On Wednesday, February 03, 2021)
- OECD Will Hold Webinar on Assessing the Dispersion Stability and Dissolution of Nanomaterials in the Environment - (Posted On Wednesday, February 03, 2021)
- Court Grants EPA’s Motion to Vacate and Remand Final Rule on “Strengthening Transparency in Pivotal Science Underlying Significant Regulatory Actions and Influential Scientific Information” - (Posted On Monday, February 01, 2021)
- FDA’s NCTR Highlights Its Nanotechnology-Related Activities in 2020 - (Posted On Saturday, January 30, 2021)
- Registration Opens for First Committee Meeting on Guidance on PFAS Testing and Health Outcomes - (Posted On Friday, January 29, 2021)
- Health, Environment, and Justice Organizations Seek Clarification from ECHA on Nano and Biocidal-Treated Products - (Posted On Wednesday, January 27, 2021)
The National Law Review recognizes Carla N. Hutton a Regulatory Analyst at Bergeson and Campbell as a Go-To Thought Leader for her consistent coverage of EPA rulemaking and stakeholder commentary opportunities, developments involving the (NNI) U.S. National Nanotechnology Initiative and regulatory changes concerning the European Commission (EC) Scientific Committee on Consumer Safety (SCCS). For more than two decades, Ms. Hutton has monitored, researched, and analyzed federal, state, and international chemical regulatory and legislative issues and her depth of knowledge provides NLR readers with updates that are focused, timely and digestible for a business audience. Ms. Hutton along with other professionals at Bergeson & Campbell provide updates several times a week on a wide range of matters involving the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and newly introduced legislation on low carbon fuel production.
Bergeson & Campbell is a Go-To Thought Leader for 2021 for its reporting on the Toxic Substances Control Act (TSCA) and Per- and Polyfluoroalkyl Substances (PFAS). Readers turn to the firm’s expert insights on the EPA's regulation and new rulemaking. Managing Partner Lynn L. Bergeson and Regulatory Analyst Carla N. Hutton alongside other professionals from Bergeson & Campbell provide readers with essential guidance they need to comply with these ever-changing government regulations.
The National Law Review names Bergeson & Campbell a Go-To Thought Leader in the field of Biotech, Food, and Drug law. Authors Lynn L. Bergeson and Carla N. Hutton covered extensively the White House’s new biotechnology initiative in their September 2022 article, “President Biden Launches National Biotechnology and Biomanufacturing Initiative.” The coverage reached thousands of legal and industry leaders and remains a valuable resource on the federal government’s new biotechnology focus.